Evidence map›Paper›PMID 20970972›Full record

ReviewCurrent opinion in immunology2011

Regulation of major histocompatibility complex class II genes.

Nancy M Choi, Parimal Majumder, Jeremy M Boss

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. CD4Science (New York, N.Y.) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. PMToxics · 2024
    Article
  13. The NLR gene family: from discovery to present day.Nature reviews. Immunology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Epigenetic gene regulation in plasma cells.Immunological reviews · 2021
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nancy M ChoiDepartment of Microbiology & Immunology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, United States.
Parimal Majumder
Jeremy M Boss
Emory University · US

Funding

Regulation of MHC Class II GenesR01GM047310 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2015
$4.6M
MHC Class II Transactivator Function and RegulationR01AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2009
$2.6M
Regulation of the MHC Class II Transactivator CIITAR56AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2010 to 2010
$383k
MHC Class II Bare Lymphocyte Syndrome factorsR21AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2003 to 2003
$342k
NIAID NIH HHS AI34000NIAID NIH HHS R01 AI034000NIAID NIH HHS R21 AI034000NIAID NIH HHS R56 AI034000NIGMS NIH HHS GM47310NIGMS NIH HHS R01 GM047310
6 · The paper itself

Abstract

The major histocompatibility complex class II (MHC-II) genes are regulated at the level of transcription. Recent studies have shown that chromatin modification is critical for efficient transcription of these genes, and a number of chromatin modifying complexes recruited to MHC-II genes have been described. The MHC-II genes are segregated from each other by a series of chromatin elements, termed MHC-II insulators. Interactions between MHC-insulators and the promoters of MHC-II genes are mediated by the insulator factor CCCTC-binding factor and are critical for efficient expression. This regulatory mechanism provides a novel view of how the entire MHC-II locus is assembled architecturally and can be coordinately controlled.

Indexed as

AnimalsChromosomesEpigenesis, GeneticGene Expression RegulationHistocompatibility Antigens Class IIHistonesHumansPromoter Regions, GeneticHistocompatibility Antigens Class IIHistones

Identifiers

PMID20970972
PMCPMC3033992
OpenAlexW2020602322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.